Press Releases May 6, 2026 04:15 PM

Precision Optics Schedules Third Quarter of Fiscal Year 2026 Conference Call for May 13, 2026

Precision Optics schedules Q3 FY2026 financial results conference call on May 13, 2026

By Leila Farooq POCI

Precision Optics Corporation, a Nasdaq-listed designer and manufacturer of advanced optical instruments for medical and defense/aerospace industries, announced its third quarter fiscal year 2026 financial results conference call will be held on May 13, 2026. The company will release its earnings and file its 10-Q after market close that day, followed by the call. The announcement focuses on logistical details for investors and analysts to discuss the upcoming results.

Precision Optics Schedules Third Quarter of Fiscal Year 2026 Conference Call for May 13, 2026
POCI

Key Points

  • Precision Optics will release Q3 FY2026 financial results and hold a conference call on May 13, 2026.
  • The company operates primarily in medical devices and defense/aerospace sectors, leveraging proprietary micro-optics, 3D and digital imaging technologies.
  • The press release reiterates the company's vertical integration and ability to deliver customized optical solutions to demanding customers worldwide.

LITTLETON, Mass., May 06, 2026 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced that it has scheduled a conference call to discuss the Company’s third quarter fiscal year 2026 financial results on Wednesday, May 13, 2026, at 5:00 p.m. ET.

The Company intends to release its financial results and to file its 10-Q after the close of the market on Wednesday, May 13, 2026, followed by the conference call.

Conference Call Details

Date and Time: Wednesday, May 13, 2026, at 5:00 p.m. ET.

Call-in Information: Interested parties can access the conference call by dialing (844) 735-3662 or (412) 317-5705.

Live Webcast Information: Interested parties can access the conference call via a live webcast, which is available at https://app.webinar.net/l90v4RE3K1N.

Replay: A teleconference replay of the call will be available for seven days, at (855) 669-9658 or (412) 317-0088, replay access code 3475317. A webcast replay will be available at https://app.webinar.net/l90v4RE3K1N.

About Precision Optics Corporation
Founded in 1982, Precision Optics is a vertically integrated optics company primarily focused on leveraging its proprietary micro-optics, 3D imaging and digital imaging technologies to the healthcare and defense/aerospace industries by providing services ranging from new product concept through mass manufacture. Utilizing its leading-edge in-house design, prototype, regulatory and fabrication capabilities as well as its Ross Optical division's high volume world-wide sourcing, inspecting and production resources, the Company is able to design and manufacture next-generation product solutions to the most challenging customer requirements. Within healthcare, Precision Optics enables next generation medical device companies around the world to meet the increasing demands of the surgical community who require more enhanced and smaller imaging systems for minimally invasive surgery as well as 3D endoscopy systems to support the rapid proliferation of surgical robotic systems. In addition to these next generation applications, Precision Optics has supplied top tier medical device companies a wide variety of optical products for decades, including complex endocouplers and specialized endoscopes. The Company is also leveraging its technical proficiency in micro-optics to enable leading edge defense/aerospace applications which require the highest quality standards and the optimization of size, weight and power. For more information, please visit www.poci.com.

About Forward-Looking Statements
This press release contains forward-looking statements within the meaning of U.S. federal securities laws. Any statements contained herein that are not statements of historical fact may be deemed to be forward-looking statements. In addition, any statements that refer to projections, forecasts, or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intends," "may," "might," "plan," "possible," "potential," "predict," "project," "should," "would" and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. The forward-looking statements contained in this press release are based on certain assumptions and analyses made by the management of the Company in light of their respective experience and perception of historical trends, current conditions, and expected future developments and their potential effects on the Company as well as other factors they believe are appropriate in the circumstances. There can be no assurance that future developments affecting the Company will be those anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond the control of the parties), or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements, including the demand for the Company's products, global supply chains and economic activity in general and other risks and uncertainties identified in the Company's filings with the SEC. Should one or more of these risks or uncertainties materialize or should any of the assumptions being made prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as may be required under applicable securities laws.

Company Contact:                                         
PRECISION OPTICS CORPORATION
550 King Street, Building A, Suite 100
Littleton, MA 01460
Telephone: 978-630-1800

Investor Contact:
LYTHAM PARTNERS, LLC
Robert Blum
Telephone: 602-889-9700
[email protected]


Risks

  • Demand for the company's products could be impacted by economic conditions and global supply chain challenges.
  • Forward-looking statements indicate uncertainties including market conditions and potential variations in actual performance versus expectations.
  • Dependence on regulatory approvals and maintaining high-quality standards critical to medical and defense industries poses operational risks.

More from Press Releases

NMI Holdings, Inc. to Participate in Upcoming Investor Conferences May 12, 2026 Fervo Energy Announces Pricing of its Upsized Initial Public Offering May 12, 2026 Titan Mining Delivers 22% Revenue Growth and Expands U.S. Critical Minerals Platform with Graphite Production May 12, 2026 Anteris Announces Results for the First Quarter of 2026 May 12, 2026 Copa Holdings Announces Monthly Traffic Statistics for April 2026 May 12, 2026